Source:http://linkedlifedata.com/resource/pubmed/id/15675574
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-1-28
|
pubmed:abstractText |
The recent development of chemotherapeutic agents for breast cancer will be reviewed. The paradigm shift from CMF to anthracycline containg regimens +/- taxanes in an adjuvant setting may be considered to decide the sequence of recommended chemotherapy for metastatic breast cancer. Recurrent breast cancer patients who never have undergone anthracycline-containing regimens should be treated with anthracycline regimens. Patients who have already received only an anthracycline-containing regimen in adjuvant therapy will be treated with taxane with or without capecitabine. For patients already having received both anthracycline and taxanes, capecitabine monotherapy will be indicated as a first-line treatment. Physicians will choose the best treatment option among chemotherapeutic agents for patients with distant metastasis.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0385-0684
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15675574-Anthracyclines,
pubmed-meshheading:15675574-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15675574-Breast Neoplasms,
pubmed-meshheading:15675574-Bridged Compounds,
pubmed-meshheading:15675574-Chemotherapy, Adjuvant,
pubmed-meshheading:15675574-Drug Administration Schedule,
pubmed-meshheading:15675574-Female,
pubmed-meshheading:15675574-Humans,
pubmed-meshheading:15675574-Lymphatic Metastasis,
pubmed-meshheading:15675574-Taxoids
|
pubmed:year |
2005
|
pubmed:articleTitle |
[Recent perspectives second-line chemotherapy for breast cancer].
|
pubmed:affiliation |
Dept. of Breast Oncology, Saitama Medical School, Japan.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|